In association with

trust in

big pharma

After a string of high profile scandals, has
public confidence in big pharma plummeted?

ISSUE 74 I SEPTEMBER 2018

The highs and lows of Humira

Therapies for chronic migraine

Exploring gene therapy

02/24/2024 12:08:01
  • Home | Trust In Big Pharma
  • Editorial
  • NSF
  • Contents
  • Daiichi Jitsugyo
  • News
  • Freudenberg
  • The Pharma Industry Briefing
  • Fisher Clinical Services Company Insight
  • Fisher Clinical Services
  • The People vs Big Pharma: tackling the industry’s trust issues
  • Scandinavian Health Ltd. Company Insight
  • Scandinavian Health Ltd.
  • Humira: the highs and lows of the world’s most successful drug
  • Wilhelm Haselmeier GmbH & Co KG Company Insight
  • Wilhelm Haselmeier GmbH & Co. KG
  • Gene therapy: talking smart solutions with Bluebird Bio
  • Moehs Iberica Company Insight
  • Moehs Iberica SL
  • A research headache: improving the understanding of chronic migraine
  • Sensitech
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Philanthropy in pharma: a look inside the ISPE Foundation
  • DelSiTech
  • Novel Oral Therapies Are An Unmet Need For Ulcerative Colitis
  • Phoenix
  • FDA removes key barrier to US biosimilar development
  • Nipro PharmaPackaging
  • Pfizer price hikes: do rare cancer drugs warrant higher prices?
  • Alpex
  • Head-to-head: competing for the most effective psoriasis drug
  • Mecmesin Company Insight
  • Mecmesin
  • Takeda to seek label expansion for Ninlaro in multiple myeloma
  • Capsugel Company Insight
  • Contract Pharmaceuticals Limited Canada
  • Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s Epidiolex
  • Ecocool
  • Abiogen Pharma
  • Illegal online pharmacies: how endemic are they?
  • Global Freight Solutions Ltd
  • The boom in medical cannabis research is set to continue
  • AtoZ-CRO GmbH Company Insight
  • AtoZ-CRO GmbH
  • Population boom will boost acute stroke market, particularly in China
  • Pall Biotech
  • Cryo Store
  • Watch Alibaba instead of Amazon in healthcare
  • WIKA - Disaster prevention
  • AstraZeneca’s Lynparza maintains lead in PARP inhibitor race
  • G.F.
  • Erdmann Design Switzerland
  • CMV presents a serious concern in HIV+ persons
  • BEA Technologies
  • Baxter
  • bDMARD therapy: adherence in the first year is key to success
  • Pharma Support Services Ltd Company Insight
  • Pharma Support Services Ltd
  • End the struggle: pathways to HEAL the opioid crisis
  • Lauda
  • AbbVie poised to overtake Gilead as hepatitis C leader
  • ILC Dover Inc
  • ViiV results show the importance of INIs to future HIV treatment
  • Pfanstiehl
  • Novartis acquires rights to atopic dermatitis candidate MOR106
  • Niconex Medical Ltd
  • Events
  • Next issue
08/24/2018 00:00:00